TUBERCULOSIS IN OLDER ADULTS: AN EPIDEMIOLOGICAL AND STATISTICAL REVIEW
Keywords:
tuberculosis; elderly; older adults; epidemiology; incidence; mortality; immunosenescence; latent TB infectionAbstract
Background. Tuberculosis (TB) caused an estimated 10.7 million cases and 1.23 million deaths in 2024. As populations age and transmission declines, an increasing share of TB occurs in older adults (≥65 years). This group has atypical presentation, frequent comorbidity and high case-fatality.
Methods. Narrative review of the WHO Global TB Report 2025, Global Burden of Disease 2021 analyses, national surveillance reports (Japan, Republic of Korea, Hong Kong SAR, United States, Australia, Uzbekistan) and peer-reviewed clinical studies.
Results. Older adults accounted for 62.5% of TB cases in Korea (2025) and about 60% (aged ≥70) in Japan (2024). Incidence rose steeply with age. It reached 101.5 per 100 000 among Koreans aged 65+ (6.4 times the rate in younger people) and 51.1 per 100 000 among Japanese aged 90+. Between 2015 and 2020, global TB deaths fell by only 3.3% in people aged 70+, against 35.3% in children under five. Classic symptoms were roughly half as frequent in older patients, and diagnostic delay was common. Mortality during treatment reached 38.1% at 80–89 years and 57.2% at 90+ years in Japan. Adverse drug reactions affected about one-third of older patients. Use of preventive treatment was lowest in the oldest groups.
Conclusion. TB control increasingly depends on older adults. Age-disaggregated surveillance, active case finding, geriatric-adapted treatment and wider preventive therapy are needed, including in Central Asian countries such as Uzbekistan.
References
1.World Health Organization. Global Tuberculosis Report 2025. Geneva: WHO; 2025. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025
2.Revvity. WHO Global Tuberculosis Report 2025: where are we now and what needs to change? 2025.
3.Cheng J, Sun YN, Zhang CY, et al. Incidence and risk factors of tuberculosis among the elderly population in China: a prospective cohort study. Infect Dis Poverty. 2020;9:13. doi:10.1186/s40249-019-0614-9
4.Tuberculosis in older adults: case studies from four countries with rapidly ageing populations in the Western Pacific Region. BMC Public Health. 2023;23.
5.A narrative review of tuberculosis in the United States among persons aged 65 years and older. J Clin Tuberc Other Mycobact Dis. 2022.
6.Treatment outcomes of tuberculosis in patients aged ≥75 years in Japan, including pyrazinamide-containing regimens. PMC8256198.
7.GBD 2021 Tuberculosis Collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy. Lancet Infect Dis. 2024.
8.Liu J, Zhou Y, Guan J, et al. Global burden of tuberculosis among adults aged 60 years and older, 1990–2021. Int J Infect Dis. 2025.
9.Tuberculosis in older people in Hong Kong SAR: age-adjusted analysis of case notification data, 1990–2015. Western Pac Surveill Response J.
10.Jhoo DC. Tuberculosis cases hit record high among elderly despite overall decline (KDCA data). The Korea Times. 24 March 2026.
11.Ministry of Health, Labour and Welfare, Japan. 2024 Tuberculosis Registry Annual Report: summary of results. Tokyo: MHLW; 2025.
12.Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2024: age group; non-US-born persons by age group.
13.Centers for Disease Control and Prevention. Provisional 2025 TB data. 2026.
14.Department of Health, Hong Kong SAR. Annual Report on Tuberculosis & Chest Service 2023.
15.Lisson et al. Tuberculosis in elderly Australians, 2011–2020. Western Pac Surveill Response J.
16.USAID. Uzbekistan Tuberculosis Roadmap Overview, Fiscal Year 2024.
17.WHO Global Health Observatory / World Bank WDI. Uzbekistan: tuberculosis incidence per 100 000. Accessed October 2026.
18.Yuz.uz. 24 March, World TB Day: key achievements of Uzbekistan in TB prevention and treatment. 2026.
19.Bureau of National Statistics, Kazakhstan. SDG indicator 3.3.2: tuberculosis incidence per 100 000.
20.Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease. Front Immunol. 2023;14:1250198.
21.Tuberculosis in an aging world. Pathogens. 2022.
22.Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. Front Immunol. 2023;14:1146704.
23.Analysis of the treatment of pulmonary tuberculosis in elderly patients at a university hospital in Rio de Janeiro, Brazil. J Bras Pneumol. 2007;33(6):691–698.
24.Alvarez S, Shell C, Berk SL. Pulmonary tuberculosis in elderly men. Am J Med. 1987;82(3):602–606.
25.Pérez-Guzmán C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? A meta-analytical review. Chest. 1999;116(4):961–967.
26.Abbara A, Collin SM, Kon OM, et al. Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review.
27.Clinical presentation and diagnostic delay of tuberculosis in patients aged 75 years and older. J Epidemiol Glob Health. 2024.
28.Epidemiological characteristics of pulmonary tuberculosis among the elderly aged 65 years and older in Yangzhou City. J Prev Med. 2023;877–880.
29.Tuberculosis in the elderly: a systematic review and a multicentre observational study (GERIA TB). University of Genoa.
30.Clinical characteristics and treatment outcomes of tuberculosis in older patients (Korea). springermedizin.de.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal